EIR Ascent Pharmaceuticals Feb 2018

Alice Tsao FDA, Jay Wong FDA$595.00 - Available Now

FDA investigators audited the Ascent Pharmaceuticals - Central Islip, NY, United States facility and issued inspectional observation (via FDA 483) on 21 Feb 2018.

Product details

  • Category:
  • Inspection end: 21 Feb 2018
  • Location: Central Islip, United States
  • FEI: 3009518416
Add To Cart